Hikma Pharmaceuticals's total assets for Q2 2024 were $4.85B, an increase of 3.57% from the previous quarter. GB:HIK total liabilities were $2.55B for the fiscal quarter, a 3.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.